Invention Grant
- Patent Title: CSF-1R inhibitors for treatment of brain tumors
-
Application No.: US15996945Application Date: 2018-06-04
-
Publication No.: US10537561B2Publication Date: 2020-01-21
- Inventor: Dylan Daniel , Johanna Joyce , James Sutton
- Applicant: Novartis AG , Sloan-Kettering Institute for Cancer Research
- Applicant Address: CH Basel US NY New York
- Assignee: Novartis AG,Sloan-Kettering Institute for Cancer Research
- Current Assignee: Novartis AG,Sloan-Kettering Institute for Cancer Research
- Current Assignee Address: CH Basel US NY New York
- Agent Michelle Han
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/175 ; A61K31/4545 ; A61K31/675 ; A61K45/06 ; C07D417/12 ; C07D417/14 ; A61K39/395

Abstract:
The present invention provides a compound of formula I; wherein R1 is an alkyl pyrazole or an alkyl carboxamide, and R2 is a hydroxycycloalkyl; or a pharmaceutically acceptable salt thereof, and compositions containing these compounds, for use to treat a brain tumor, particularly glioblastoma. The invention provides effective treatment of a brain tumor and can be used by oral administration of a compound of Formula I as further described herein. The invention also provides a method to treat a subject having a brain tumor such as glioblastoma, wherein the method comprises administering to the subject an effective amount of a compound of Formula I. Gene signatures correlated with successful treatment using these methods are also disclosed.
Public/Granted literature
- US20190030013A1 CSF-1R INHIBITORS FOR TREATMENT OF BRAIN TUMORS Public/Granted day:2019-01-31
Information query
IPC分类: